iBio, AstralBio announce development of antibody inhibiting Activin E
Bio (IBIO) in collaboration with AstralBio announced the development of an antibody that inhibits the function of Activin E, a promising ...
FierceBiotech6d
iBio pens $29M biobucks deal with AstralBio for obesity med designed to preserve muscle mass
San Diego-based iBio has signed a backloaded agreement with its existing partner AstralBio for a preclinical anti-myostatin ...
iBio Discovers Novel Antibody Targeting Activin E in Collaboration with AstralBio
Achievement strengthens iBio’s partnered cardiometabolic and obesity program while showcasing its proprietary AI-driven drug ...
iBio Expands Pipeline with New Antibody Agreement
An update from Ibio ( (IBIO) ) is now available. iBio, Inc. announced an exclusive agreement with AstralBio to license a long ...
BioWorld3d
Ibio licenses long-acting anti-myostatin antibody from Astralbio
Ibio Inc. has expanded its cardiometabolic and obesity treatment development program by in-licensing a long-acting anti-myostatin antibody from Astralbio Inc. The antibody, now named IBIO-600, was ...
manilatimes2d
Plug to Participate in Goldman Sachs Energy, CleanTech & Utilities Conference
SLINGERLANDS, N.Y., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive ...
The New York Times1d
World News
After Donald Trump suggested he might take over Greenland by force, the consensus among the island’s population appears to be bewilderment and anxiety. By Jeffrey Gettleman and Maya Tekeli The ...